357: The upheaval of CDC's vaccine panel, and drug pricing confusion
First, we chat about how pharma companies still don’t have much clarity on Trump’s most-favored nation drug pricing policy, biotech’s next big takeout target, and more. Then we bring on Kathryn Edward...
12 Juni 202545min
356: An AI experiment at the FDA & Novo trailing in the obesity drug race
The FDA has rolled out an internal AI tool called Elsa that, unlike its namesake Disney character, can’t seem to let go of mistakes. Our colleague Brittany Trang joins to explain. And it’s always a fu...
5 Juni 202533min
355: Moderna’s vaccine hit, the MAHA report, and an ASCO preview
The American Society of Clinical Oncology, or ASCO, kicks off its annual meeting this weekend in Chicago. We discuss what to watch at the meeting. Then, STAT’s infectious disease reporter Helen Bransw...
29 Maj 202536min
354: Uncertainty in CRISPR world and the start of more M&A
We chat about M&A deals picking up, leadership changes at Novo, and recent FDA advisory committee meetings for cancer drugs. We also bring on STAT reporter Jason Mast to talk about the latest research...
22 Maj 202541min
353: Trump's drug-pricing plan and a potential Theranos 2.0
We chat about the mixed sentiment in biotech markets these days and a new blood-testing company formed by Elizabeth Holmes' husband. We also bring on STAT's D.C. correspondent Daniel Payne to talk abo...
15 Maj 202525min
352: A firebrand takes oversight of vaccines, gene therapies
Matt Herper joins Adam and Allison to examine Prasad's appointment and the band of outsiders now in charge of U.S. health agencies. He and Adam debate just how disruptive Prasad's tenure could be.
8 Maj 202526min
351: It's gonna be May (in biotech)
On this week’s episode of the Readout LOUD, we review President Trump’s first 100 days, the return of biotech M&A, strong drug launches, and Eli Lilly’s PBM problem. The first 100 days of the Trump ...
1 Maj 202535min
350: Pharma tariffs, and a 'sunshine day' for biotech stocks
How did Ireland become a hotspot for pharmaceutical manufacturing? What are the products that will come out of Flagship's latest startup centered around "preemptive medicine"? And who among the co-hos...
24 Apr 202531min
